Skip to content

Clinical trials

Withdrawn Phase 1/2 Prostatic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 1/2 Status: Withdrawn Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20101
20111
20141
20211
20221
20242
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Baptist Health South Florida1
Columbia University1
Emmanuel Antonarakis, MD1
Masonic Cancer Center, University of Minnesota1
Memorial Sloan Kettering Cancer Center1
Nuvation Bio Inc.1
Roswell Park Cancer Institute1
University of Florida1
University of Texas Southwestern Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms11
Breast Neoplasms2
Neoplasm Metastasis2
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Renal Cell1
Kidney Neoplasms1
Lung Neoplasms1
Melanoma1
Pain1
Prostatic Neoplasms, Castration-Resistant1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.